Inflammatory Bowel Disease

New imaging agent provides better picture of the gut

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

Jul 24, 2014
popularity 4 / 5 (5) | comments 0

Researchers unlock the protein puzzle

By using brightly hued dyes, George Mason University researchers discovered an innovative way to reveal where proteins touch each other, possibly leading to new treatments for cancer, arthritis, heart disease and even lung ...

Jul 23, 2014
popularity not rated yet | comments 0

When good gut bacteria get sick

Being sick due to an infection can make us feel lousy. But what must the ecosystem of bacteria, or microbiota, colonizing our guts be going through when hit with infection? A study from Brigham and Women's ...

Jul 11, 2014
popularity 4.8 / 5 (9) | comments 0

Unsuspected aspect of immune regulation revealed

Until now, the immune cells known as 'B cells' have been thought to specialise only in the production of antibodies. A discovery by Garvan immunologists shows they also have a role to play in regulating another ...

Jul 01, 2014
popularity not rated yet | comments 0

In medicine, inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. The major types of IBD are Crohn's disease and ulcerative colitis.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

At last, hope for ALS patients?

U of T researchers have found a missing link that helps to explain how ALS, one of the world's most feared diseases, paralyses and ultimately kills its victims. The breakthrough is helping them trace a path to a treatment ...

Stem cells from nerves form teeth

Researchers at Karolinska Institutet in Sweden have discovered that stem cells inside the soft tissues of the tooth come from an unexpected source, namely nerves. These findings are now being published in the journal Nature and co ...

$1,000 pill now hepatitis C treatment of choice

(AP)—A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.